Evidence map›Paper›PMID 24378816›Full record

ArticleJournal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life.

Suzanne Ameringer, R K Elswick, Wally Smith

Registry-linked trialAbstract read
In one paragraph

Article in Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03291613 (PINPOINT), which is not on this map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03291613 nacompletednot on this map

PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Management

TypeinterventionalSponsorKlein Buendel, Inc.Ran2017 to 2017Enrolled13ConditionsSickle Cell DiseaseArmsPinpoint App
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Safety and efficacy of monthly high-dose vitamin DEuropean journal of pediatrics · 2024
    Trial
  4. Trial
  5. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Trial
  6. Vitamin D Supplementation Improves Health-Related Quality of Life and Physical Performance in Children with Sickle Cell Disease and in Healthy Children.Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
    Trial
  7. Frailty phenotype in adults with sickle cell disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Illness Intrusiveness in Adults with Sickle Cell Disease: The Role of Fatigue.Journal of clinical psychology in medical settings · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suzanne Ameringer1Virginia Commonwealth University, Richmond, VA, USA.
R K Elswick
Wally Smith

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR031990 · NCRR · VIRGINIA COMMONWEALTH UNIVERSITY · PI CLORE, JOHN N. · 2010 to 2011
$7.7M
Center of Excellence in Biobehavioral Approaches to Symptom ManagementP30NR011403 · NINR · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRAP, MARY JO · 2009 to 2013
$2.2M
PAIN IN SICKLE CELL EPIDEMIOLOGIC STUDYR01HL064122 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SMITH, WALLY R · 2001 to 2003
$2.2M
Virginia Comprehensive Sickle Cell Center-Center: Basic & Translational ResearchU54HL090516 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI LLOYD, JOYCE A. · 2008 to 2011
$1.4M
Virginia Commonwealth University Sickle Cell Disease Clinical NetworkU10HL083732 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SMITH, WALLY R · 2006 to 2008
$904k
NCRR NIH HHS UL1RR031990NHLBI NIH HHS 1 R01 HL 64122NHLBI NIH HHS 1 U10 HL083732NHLBI NIH HHS 1 U54 HL090516NHLBI NIH HHS U54 HL090516NINR NIH HHS P30 NR011403
6 · The paper itself

Abstract

This descriptive, correlational study examined fatigue and potential biological and behavioral correlates in adolescents and young adults with sickle cell disease. Sixty adolescents and young adults with sickle cell disease completed the Brief Fatigue Inventory, Multidimensional Fatigue Symptom Inventory-Short Form, Patient Reported Outcomes Measurement Information System (PROMIS) fatigue short form and measures of pain, sleep quality, anxiety, depressive mood, stress, disease severity, and quality of life. Blood samples were obtained for hemoglobin and cytokines. Fatigue scores were mostly moderate in severity. Fatigue interfered to a moderate degree with daily activities and correlated significantly with pain, sleep quality, state and trait anxiety, depressive mood, stress, and quality of life. Fatigue was correlated with hemoglobin on the PROMIS measure. Fatigue was not correlated with cytokines or age, nor differed by disease severity. Fatigue was common in these adolescents and young adults, interfered with daily activities such as school, work and exercise, and significantly correlated with several potentially modifiable factors. As life expectancy increases in sickle cell disease, research is needed to test interventions to reduce fatigue.

Indexed as

FatigueQuality of LifeAdolescentAdultAnemia, Sickle CellCross-Sectional StudiesFemaleHumansMaleSeverity of Illness IndexYoung Adultadolescents and young adultsfatiguepainquality of lifesickle cell disease

Identifiers

PMID24378816
PMCPMC3982311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.